What Is BIO-key International, Inc. (BKYI) Worth in 2026?
According to the CirclFi Deep Alpha Valuation Engine, BIO-key International, Inc.'s intrinsic value is estimated at a composite $9.35, showing conflicting signals at the current price of $4.89. While the average implied return is +91.2%, model disagreement is elevated with a gap of +524.9% between the most bullish and bearish estimates. The most optimistic model, EPV, places fair value at $26.86 (+449.4%), while First Chicago — the most conservative — estimates $1.19 (-75.6%). This +524.9% gap reflects genuine analytical uncertainty about BIO-key International, Inc.'s intrinsic worth.
What Do the Models Say About BKYI?
11 of 13 models are currently active for BKYI. Of these, 7 models suggest upside while 4 models suggest overvaluation. The Bayesian DCF estimates BKYI's intrinsic value at $2.45, implying -49.9% downside from the current price. See which stocks rank higher →
How Does BKYI Rank in Services-Prepackaged Software?
Among 208 Services-Prepackaged Software stocks, BKYI ranks #129 by Quality of Company score. CirclFi's QOC score of 6.5/10 evaluates 32 fundamental signals. A score of 6.5 indicates above-average quality.
See all Most Undervalued Services-Prepackaged Software Stocks →
Within the Services-Prepackaged Software space, BIO-key International, Inc. competes in an environment where net revenue retention (NRR) often separates market leaders from laggards. Understanding these industry-specific dynamics is essential context for interpreting our model outputs.
Is BKYI a Value Trap?
CirclFi's Value Trap algorithm assigns BKYI a score of 24/100 (SAFE). This indicates minimal risk. Fundamentals are healthy. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →
Multi-Model Methodology
11 of 13 models are active for BIO-key International, Inc.. Broad coverage provides high confidence. Each model applies a fundamentally different valuation philosophy. See the complete methodology →
According to the CirclFi Quality of Company (QOC) framework, which evaluates 32 signals including margin stability, revenue growth trajectory, leverage, and free cash flow generation, BIO-key International, Inc. is rated at 6.5/10. This solid-tier score maintains reasonable quality metrics with some areas for improvement.
The gap between the most bullish and bearish model spans +524.9% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →
Data Sources & Confidence
Every BKYI valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →
Across BKYI's 11 active models, average confidence is 24%. Lower confidence may reflect limited history or high volatility.
CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →
Buy with Gumroad